BRIEF

on Affluent Medical (isin : FR0013333077)

Affluent Medical to Engage in Key Scientific Conferences

Affluent Medical, a French clinical-stage medtech company, will participate in three major scientific events in late 2024. The events include the 38th EACTS Annual Meeting in Lisbon, ICS 2024 in Madrid, and the PCR London Valves in the UK. These conferences provide a platform for Affluent Medical to showcase advances in their cutting-edge medical devices.

The company specializes in minimally invasive solutions for urinary incontinence and mitral insufficiency, impacting over 600 million people worldwide. Notably, Affluent Medical has made significant progress with their mitral valve technologies collaboration with Edwards Lifesciences and early results of their artificial sphincter, Artus.

Affluent's product innovations, such as the adjustable mitral ring KaliosTM and biomimetic valve Epygon, demonstrate promising potentials to enhance cardiac and urinary treatments.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Affluent Medical news